In addition, due to this intertumoral heterogeneity, different regions may exhibit distinct genetic profiles and tumor microenvironments, complicating the reliability and applicability of biomarkers such as TILs and PD-L1 expression [137,138,139]. The gene discussed is CD274; the disease is neoplasm.